10-Q · July 29, 2026
Annaly reported Q2 EPS of $0.79, above both Q1 2026 EPS of $0.33 and Q2 2025 EPS of $0.03, while supplied revenue of $1.812 billion was $122.2 million above consensus. The provided filing excerpt does not include the…
Earnings analysis · 10-Q
Filed October 28, 2026 · Our reading of the company's report
The latest report
Annaly reported EPS of $0.80, a 2.56% beat versus the $0.78 estimate, but quarterly EPS declined 24.5% from $1.06 in Q2 2026 and 33.3% from $1.20 in Q3 2025. The extracted 10-Q does not provide current gross margin,…
Annaly reported EPS of $0.80, a 2.56% beat versus the $0.78 estimate, but quarterly EPS declined 24.5% from $1.06 in Q2 2026 and 33.3% from $1.20 in Q3 2025. The extracted 10-Q does not provide current gross margin, operating margin, free cash flow, segment results, balance-sheet detail, or quantitative forward guidance. Controls were effective, no material legal proceedings were pending, and management reported no material changes to previously disclosed risk factors.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported EPS was $0.80, exceeding the $0.78 estimate by $0.02, or 2.56%.
Management reported that disclosure controls and procedures were effective as of September 30, 2026, with no changes in internal controls that materially affected or were reasonably likely to materially affect reporting.
The company retained $1.5 billion of authorization under its common-stock repurchase program through December 31, 2029.
No material legal proceedings were pending as of September 30, 2026.
EPS of $0.80 declined from $1.06 in Q2 2026, a decrease of $0.26, or 24.5%, and from $1.20 in Q3 2025, a decrease of $0.40, or 33.3%.
No shares were repurchased during the quarter despite $1.5 billion of remaining authorization, indicating that the repurchase program provided no capital-return benefit during Q3 2026.
The 10-Q states there were 0 material changes to the risk factors disclosed in the most recent Form 10-K, so the filing provides limited incremental detail on emerging risks.
No quantitative revenue or EPS outlook was provided in the extracted 10-Q. The filing does not disclose a forward guidance range.
Annaly reported Q2 EPS of $0.79, above both Q1 2026 EPS of $0.33 and Q2 2025 EPS of $0.03, while supplied revenue of $1.812 billion was $122.2 million above consensus. The provided filing excerpt does not include the…
Annaly Capital Management reported strong Q1 2026 results with revenues reaching $1.724 billion, significantly surpassing estimates of $506.1 million. Diluted EPS was $0.76, beating the estimated $0.74, reflecting…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.